These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21945484)

  • 41. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
    Boundy VA; Pacheco MA; Guan W; Molinoff PB
    Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
    Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.
    Torvinen M; Kozell LB; Neve KA; Agnati LF; Fuxe K
    J Mol Neurosci; 2004; 24(2):173-80. PubMed ID: 15456930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
    Chio CL; Lajiness ME; Huff RM
    Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
    Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
    Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dopamine D₁ receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brain.
    Finnema SJ; Bang-Andersen B; Jørgensen M; Christoffersen CT; Gulyás B; Wikström HV; Farde L; Halldin C
    Synapse; 2013 Sep; 67(9):586-95. PubMed ID: 23504964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET).
    Hodé Y; Benyamina A; Arbus C; Reimold M
    Psychopharmacology (Berl); 2011 Oct; 217(3):315-21. PubMed ID: 21479533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity of binding of high-affinity dopamine receptor radioligands to increased synaptic dopamine.
    Gatley SJ; Gifford AN; Carroll FI; Volkow ND
    Synapse; 2000 Dec; 38(4):483-8. PubMed ID: 11044896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allosteric Interactions between Adenosine A
    Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine D
    Ågren R; Stepniewski TM; Zeberg H; Selent J; Sahlholm K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P; Ko F; Willeit M; McCormick P; Ginovart N
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
    Mach RH; Nader MA; Ehrenkaufer RL; Line SW; Smith CR; Luedtke RR; Kung MP; Kung HF; Lyons D; Morton TE
    Synapse; 1996 Dec; 24(4):322-33. PubMed ID: 10638823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.
    Matuskey D; Gaiser EC; Gallezot JD; Angarita GA; Pittman B; Nabulsi N; Ropchan J; MaCleod P; Cosgrove KP; Ding YS; Potenza MN; Carson RE; Malison RT
    Drug Alcohol Depend; 2015 Sep; 154():167-73. PubMed ID: 26164205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
    Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
    Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo.
    Gallezot JD; Beaver JD; Gunn RN; Nabulsi N; Weinzimmer D; Singhal T; Slifstein M; Fowles K; Ding YS; Huang Y; Laruelle M; Carson RE; Rabiner EA
    Synapse; 2012 Jun; 66(6):489-500. PubMed ID: 22213512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.